Palatin net loss narrows to $8.38 million in FY26; revenue turns to $13.19 million
Bitget2026/09/28 11:31- Palatin posted a net loss of $8.38 million, narrowing from $17.31 million a year earlier.
- Loss per share improved to $2.96 from $32.15 in the prior fiscal year.
- Revenue was $13.19 million versus no revenue a year earlier, including $9.4 million tied to Boehringer Ingelheim.
- Cash and cash equivalents rose to $7.49 million from $2.56 million at June 30, 2025; it flagged a need for additional funding.
- Phase 1 SAD/MAD for a once-weekly injectable MC4R peptide is targeted for 1H 2027, with initial data targeted in 2H 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Current Spread in Yield Basis Points Germany 3.475 % Australia 5.347 % 187.2 Belgium 4.339 % 86.4 Canada 3.944 % 46.9 Denmark 3.268 % -20.7 France 4.866 % 139.1 Italy 4.604 % 113.0 Japan 3.100 % -37.5 Netherlands 3.577 % 10.2 Spain 4.087 % 61.2 Sweden 3.146 % -32.9 U.K. 5.369 % 189.4 U.S. 5.267 % 179.2 Source: Tullett Prebon via FactSet (END) Dow Jones Newswires October 04, 2026 21:10 ET (01:10 GMT)
‘Ethereum risks being left behind’ – Analysts debate L1’s role in tokenization boom
